- 数据类型
- 行业分类
- 数据时间近三天近一周近一个月近半年近一年清空选项
- CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
数据来源：公司财报2025-05-07 - SCINAI IMMUNOTHERAPEUTICS LTD.
数据来源：公司财报2025-05-07 - SCINAI IMMUNOTHERAPEUTICS LTD.
数据来源：公司财报2025-05-07 - Fair Value Measurement at March 31, 2025 Using:
数据来源：公司财报2025-05-07 - 4. Prepaid Expenses and Other Current Assets
数据来源：公司财报2025-05-07 - 5. Accrued Expenses and Other Current Liabilities
数据来源：公司财报2025-05-07 - Three Months Ended March 31,
数据来源：公司财报2025-05-07 - Three Months Ended March 31,
数据来源：公司财报2025-05-07 - Cash Flows
数据来源：公司财报2025-05-07 - (Unaudited)
数据来源：公司财报2025-05-07 - SHOULDERUP TECHNOLOGY ACQUISITION CORP. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023
数据来源：公司财报2025-05-07 - December 31, 2024
数据来源：公司财报2025-05-07 - Note 5. Property and equipment
数据来源：公司财报2025-05-07 - Marketable securities as of December 31, 2024 consisted of the following (in thousands):
数据来源：公司财报2025-05-07 - Table of Contents
数据来源：公司财报2025-05-07 - Three Months Ended March 31,
数据来源：公司财报2025-05-07 - Cash flows
数据来源：公司财报2025-05-07 - Condensed Consolidated Statements of Operations and Comprehensive Loss (in thousands, except share and per share amounts) (Unaudited)
数据来源：公司财报2025-05-07 - Item 6. Exhibits.
数据来源：公司财报2025-05-07 - See accompanying notes to unaudited condensed consolidated financial statements.
数据来源：公司财报2025-05-07 - Three Months Ended March 31,
数据来源：公司财报2025-05-07